Thermo Fisher Scientific (TMO) Gross Profit (2009 - 2026)

Thermo Fisher Scientific has reported Gross Profit for 18 years, with the latest figure at $8.3 billion in Q2 2026.

• Gross Profit for Q2 2026 came in at $8.3 billion, up 9.56% year-over-year; the trailing twelve-month figure through Jun 2026 was $32.3 billion (up 6.22% YoY), and the FY2025 annual result was $31.2 billion, up 3.06% from the prior year.
• Gross Profit improved to $8.3 billion in Q2 2026, from $7.7 billion in the prior quarter.
• Over five years, Gross Profit peaked at $8.5 billion in Q4 2025 and troughed at $7.1 billion in Q1 2024.
• A 5-year average of $7.6 billion and a median of $7.5 billion in 2022 frame the typical range for Gross Profit.
• The largest YoY upside for Gross Profit was 25.89% in 2022 against a maximum downside of 22.74% in 2022.
• A 5-year view of Gross Profit shows it stood at $7.8 billion in 2022, then retreated by 2.85% to $7.5 billion in 2023, then gained by 8.07% to $8.2 billion in 2024, then rose by 4.13% to $8.5 billion in 2025, then fell by 1.75% to $8.3 billion in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $8.3 billion in Q2 2026, $7.7 billion in Q1 2026, and $8.5 billion in Q4 2025.